Below is an excerpt from an article posted on ModernHealth.com. A link to the full article on their page appears at the end of the excerpt.
For eight years, Beth Joyner Waldron has counted on Eliquis to treat clots in her lungs and legs.
In November 2021, she received a letter from CVS Caremark telling her the pharmacy benefit manager is excluding Eliquis from its formulary next year. Receiving the letter made her emotional.
Just a year ago, her father bled to death. Joyner Waldron said he had an adverse reaction to his blood thinner.
“I nearly died from my blood clots 18 years ago and I know from my dad’s experience the treatment carries a high risk,” Joyner Waldron said. “I’ve been stable, I’ve not had any bleeds, and then I get this letter saying I have to switch meds, that obviously induces anxiety.”
She also was angry that the letter did not include information on how to appeal the decision.
As of January 1, one of the nation’s largest pharmacy benefit managers no longer covers a blood thinner that Joyner Waldron and an estimated 3 million others rely on to prevent and treat blood clots. Just five weeks before the formulary change was made, CVS’ $39 billion Caremark subsidiary sent letters to its commercial enrollees, alerting them that they would need to switch from Bristol-Myers Squibb’s Eliquis to Janssen Pharmaceuticals’ Xarelto, both anticoagulants that experts say have never been proved to be interchangeable through randomized control trials.
To read the rest of this article, please visit the site where this article originally appeared: https://www.modernhealthcare.com/patient-care/cvs-adds-more-vital-drugs-formulary-exclusions
We do our best to identify relevant and interesting news in the healthcare industry published by all sources. We encourage everyone who would like to read more than the initial excerpt provided here to access the full text via the original publisher.
Mike is a Senior Consultant for The Pharmacy Group (TPG). TPG provides consulting services to healthcare service, information technology, and pharmaceutical companies to grow revenue and improve the financial performance of their products and services.
Henry is a senior consultant with The Pharmacy Group (TPG). TPG provides consulting services to healthcare service, information technology, and pharmaceutical companies to grow revenue and improve the financial performance of their products and services.



Gayle is a Senior Consultant with TPG Data Services (TPG-DS). TPG-DS and our team of senior healthcare and clinical consultants are transforming the way providers and payors monitor healthcare information to control costs and enhance efficiencies.
Winston Wong is a Senior Consultant with The Pharmacy Group (TPG). TPG provides consulting services to healthcare service, information technology, and pharmaceutical companies to grow revenue and improve the financial performance of their products and services.
Jeff joined The Pharmacy Group (TPG) in August 2008 to support its administrative functions. Over the years he has taken on additional responsibilities including marketing initiatives, client communications, and general web support. As a vice president Jeff is primarily responsible for attendee recruitment for all TPG activities, from the planning and strategy of recruitment to the execution and oversight of those initiatives.
Rich Balest has served as a health industry consultant utilizing over 25 years of experience in data mining, data modeling, data warehousing, and information delivery. Rich has comprehensive experience analyzing detailed claims and eligibility from CMS, insurance companies, and managed care organizations including prescription benefit managers (PBM), and account and medical record detailed patient data from hospital patient accounting systems, clinical ancillary systems, and professional and institutional billing systems.
Marjorie Pestel Zimmerman, MS, BS Pharm, is a registered pharmacist with diverse experience in the healthcare industry. During her practice in a large tertiary care center, she held numerous positions, including decentralized clinical pharmacist and Assistant Director of Operations within the pharmacy department. As a consultant for a psychiatric hospital, she performed medical staff drug usage evaluations and led patient medication groups.
